<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>37-ANAKINRA.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ANAKINRA" rxcui="72435">
<ATC code="L04AC03" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="ANTI-TNF ALPHA" code="4ABO" /></DRUG2>
<DESCRIPTION>Increased risk of serious infections and of neutropenia.</DESCRIPTION>
<SEVERITY> Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>37-ANAKINRA.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ANAKINRA" rxcui="72435">
<ATC code="L04AC03" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="ETANERCEPT" rxcui="214555">
<ATC code="L04AB01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increased risk of serious infections and of neutropenia</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
</INTERACTIONS>
